Literature DB >> 23607783

Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.

P Martinez-Martin1, K R Chaudhuri, J M Rojo-Abuin, C Rodriguez-Blazquez, M Alvarez-Sanchez, T Arakaki, A Bergareche-Yarza, A Chade, N Garretto, O Gershanik, M M Kurtis, J C Martinez-Castrillo, A Mendoza-Rodriguez, H P Moore, M Rodriguez-Violante, C Singer, B C Tilley, J Huang, G T Stebbins, C G Goetz.   

Abstract

BACKGROUND AND
PURPOSE: Although Parkinson's disease (PD) is characterized by typical motor manifestations, non-motor symptoms (NMS) are an outstanding part of the disease. At present, several specific instruments for assessment of NMS are available. The objective of our study was to determine the performance of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Part I - Non-Motor Aspects of Experiences of Daily Living (nM-EDL) compared with the Non-Motor Symptoms Scale (NMSS).
METHODS: To this purpose, 434 consecutive patients with PD were included in an international, observational, cross-sectional study. The association between scores of both scales was determined by the Spearman rank correlation coefficient. Equations for transformation of total score of a scale to the other were constructed from weighted regression models and both, transformed and observed score, contrasted by means of the Lin's Concordance Correlation Coefficient (LCCC) and Bland-Altman plot.
RESULTS: As a whole, the prevalence of the NMS according to each scale was quite similar, and most of the correlations between their corresponding components were high (r(S) > 0.60). The total score correlation of the MDS-UPDRS Part I with the NMSS was high (r(S) = 0.81). Concerning the transformed scores, estimated scores only partially approach the observed ones (sharing about 60-64% of the variance) because residual variance increased with increasing magnitudes of the scores, i.e. the most severe patients (Bland-Altman plot; LCCC < 0.60 for severe patients).
CONCLUSIONS: (i) MDS-UPDRS Part I (nM-EDL) and NMSS showed a strong convergent validity; (ii) however, transformed scores using the equations from weighted regression models showed that for patients with the most severe NMS they are not concordant.
© 2013 The Author(s) European Journal of Neurology © 2013 EAN.

Entities:  

Keywords:  MDS-UPDRS; Non-Motor Symptoms Scale; Parkinson's disease; non-motor symptoms; rating scales

Mesh:

Year:  2013        PMID: 23607783     DOI: 10.1111/ene.12165

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  27 in total

1.  The correlation of non-motor symptoms and sleep on balance in Parkinson's disease patients with normal cognition and mild cognitive impairment.

Authors:  Mevhibe Saricaoglu; Nesrin Helvaci Yilmaz; Fahriye Feriha Ozer; Lutfu Hanoglu
Journal:  Ir J Med Sci       Date:  2021-01-15       Impact factor: 1.568

Review 2.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

3.  Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

Authors:  Brit Mollenhauer; Johannes Zimmermann; Friederike Sixel-Döring; Niels K Focke; Tamara Wicke; Jens Ebentheuer; Martina Schaumburg; Elisabeth Lang; Ellen Trautmann; Henrik Zetterberg; Peggy Taylor; Tim Friede; Claudia Trenkwalder
Journal:  Neurology       Date:  2016-05-06       Impact factor: 9.910

Review 4.  Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.

Authors:  Daniel Martinez-Ramirez; Michael S Okun; Michael S Jaffee
Journal:  Neurodegener Dis Manag       Date:  2016-07-13

5.  Differential impact of individual autonomic domains on clinical outcomes in Parkinson's disease.

Authors:  Katherine Longardner; Aristide Merola; Irene Litvan; Alberto Maria De Stefano; Simona Maule; Fabrizio Vallelonga; Leonardo Lopiano; Alberto Romagnolo
Journal:  J Neurol       Date:  2022-06-16       Impact factor: 6.682

6.  Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.

Authors:  Giovanni Defazio; Marta Guerrieri; Daniele Liuzzi; Angelo Fabio Gigante; Vincenzo di Nicola
Journal:  Neurol Sci       Date:  2015-11-28       Impact factor: 3.307

7.  Apathy and associated factors in Mexican patients with Parkinson's disease.

Authors:  Mayela Rodríguez-Violante; Paulina González-Latapi; Amin Cervantes-Arriaga; Daniel Martínez-Ramírez; Salvador Velázquez-Osuna; Azyadeh Camacho-Ordoñez
Journal:  Neurol Sci       Date:  2013-12-05       Impact factor: 3.307

Review 8.  Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.

Authors:  Anne Pavy-Le Traon; Nikki Cotterill; Gerard Amarenco; Susanne Duerr; Horacio Kaufmann; Heinz Lahrmann; François Tison; Gregor K Wenning; Christopher G Goetz; Werner Poewe; Cristina Sampaio; Anette Schrag; Olivier Rascol; Pablo Martinez-Martin; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2018-10-25

Review 9.  Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough.

Authors:  Upasana Ganguly; Sukhpal Singh; Soumya Pal; Suvarna Prasad; Bimal K Agrawal; Reena V Saini; Sasanka Chakrabarti
Journal:  Front Aging Neurosci       Date:  2021-07-08       Impact factor: 5.750

10.  Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up.

Authors:  Diego Santos-García; Teresa de Deus; Carlos Cores; Hector Canfield; Jose M Paz González; Cristina Martínez Miró; Lorena Valdés Aymerich; Ester Suárez; Silvia Jesús; Miquel Aguilar; Pau Pastor; Lluis Planellas; Marina Cosgaya; Juan García Caldentey; Nuria Caballol; Ines Legarda; Jorge Hernández-Vara; Iria Cabo; Lydia López Manzanares; Isabel González Aramburu; Maria A Ávila Rivera; Maria J Catalán; Victor Nogueira; Victor Puente; Julio Dotor; Carmen Borrué; Berta Solano; Maria Álvarez Sauco; Lydia Vela; Sonia Escalante; Esther Cubo; Francisco Carrillo; Juan C Martínez Castrillo; Pilar Sánchez Alonso; Gemma Alonso; Nuria López Ariztegui; Itziar Gastón; Jaime Kulisevsky; Marta Blázquez; Manuel Seijo; Javier Rúiz Martínez; Caridad Valero; Monica Kurtis; Oriol de Fábregues; Jessica Ardura; Ruben Alonso; Carlos Ordás; Luis M López Díaz; Darrian McAfee; Pablo Martinez-Martin; Pablo Mir
Journal:  J Pers Med       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.